Pancreatic Cancer Research

Journal articleCell Cycle2020

Overexpression of MYEOV predicting poor prognosis in patients with pancreatic ductal adenocarcinoma.

Journal
Cell Cycle
Published
18 May 2020
Citations
18
Type
Article

These are the paper’s bibliographic details. A summary of its population, design, endpoints and findings, each tied to a quote, has not been written for this paper yet.

Ask this document

Answers come only from this document’s own text, as highlighted quotes. If it doesn’t say, you are told so instead of given a guess.

Try

Source text

abstract license unknown

Myeloma Overexpressed (MYEOV) is closely related to cell growth and differentiation in many cancer types. However, the role of this protein-coding gene in pancreatic ductal adenocarcinoma (PDAC) has rarely been investigated. … Excerpt only: this text is the publisher’s. Read it in full at the source.